585 related articles for article (PubMed ID: 21824948)
21. Lifestyle Intervention With or Without Lay Volunteers to Prevent Type 2 Diabetes in People With Impaired Fasting Glucose and/or Nondiabetic Hyperglycemia: A Randomized Clinical Trial.
Sampson M; Clark A; Bachmann M; Garner N; Irvine L; Howe A; Greaves C; Auckland S; Smith J; Turner J; Rea D; Rayman G; Dhatariya K; John WG; Barton G; Usher R; Ferns C; Pascale M;
JAMA Intern Med; 2021 Feb; 181(2):168-178. PubMed ID: 33136119
[TBL] [Abstract][Full Text] [Related]
22. Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose.
Pascale M; Murray N; Bachmann M; Barton G; Clark A; Howe A; Greaves C; Sampson M
BMC Public Health; 2017 Jan; 17(1):31. PubMed ID: 28056894
[TBL] [Abstract][Full Text] [Related]
23. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
Li G; Zhang P; Wang J; Gregg EW; Yang W; Gong Q; Li H; Li H; Jiang Y; An Y; Shuai Y; Zhang B; Zhang J; Thompson TJ; Gerzoff RB; Roglic G; Hu Y; Bennett PH
Lancet; 2008 May; 371(9626):1783-9. PubMed ID: 18502303
[TBL] [Abstract][Full Text] [Related]
24. Effects of a culturally adapted lifestyle intervention on cardio-metabolic outcomes: a randomized controlled trial in Iraqi immigrants to Sweden at high risk for Type 2 diabetes.
Siddiqui F; Kurbasic A; Lindblad U; Nilsson PM; Bennet L
Metabolism; 2017 Jan; 66():1-13. PubMed ID: 27923444
[TBL] [Abstract][Full Text] [Related]
25. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.
Gilis-Januszewska A; Lindström J; Tuomilehto J; Piwońska-Solska B; Topór-Mądry R; Szybiński Z; Peltonen M; Schwarz PE; Windak A; Hubalewska-Dydejczyk A
BMC Public Health; 2017 Feb; 17(1):198. PubMed ID: 28202029
[TBL] [Abstract][Full Text] [Related]
26. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.
Stevens JW; Khunti K; Harvey R; Johnson M; Preston L; Woods HB; Davies M; Goyder E
Diabetes Res Clin Pract; 2015 Mar; 107(3):320-31. PubMed ID: 25638454
[TBL] [Abstract][Full Text] [Related]
27. Baseline osteocalcin levels and incident diabetes in a 3-year prospective study of high-risk individuals.
Liatis S; Sfikakis PP; Tsiakou A; Stathi C; Terpos E; Katsilambros N; Makrilakis K
Diabetes Metab; 2014 Jun; 40(3):198-203. PubMed ID: 24529960
[TBL] [Abstract][Full Text] [Related]
28. Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.
Zhang L; Zhang Y; Shen S; Wang X; Dong L; Li Q; Ren W; Li Y; Bai J; Gong Q; Kuang H; Qi L; Lu Q; Cheng W; Liu Y; Yan S; Wu D; Fang H; Hou F; Wang Y; Yang Z; Lian X; Du J; Sun N; Ji L; Li G;
Lancet Diabetes Endocrinol; 2023 Aug; 11(8):567-577. PubMed ID: 37414069
[TBL] [Abstract][Full Text] [Related]
29. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.
Luo Y; Paul SK; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Wang H
J Diabetes Res; 2017; 2017():7602408. PubMed ID: 28168204
[No Abstract] [Full Text] [Related]
30. The effect of medical nutrition therapy by a registered dietitian nutritionist in patients with prediabetes participating in a randomized controlled clinical research trial.
Parker AR; Byham-Gray L; Denmark R; Winkle PJ
J Acad Nutr Diet; 2014 Nov; 114(11):1739-48. PubMed ID: 25218597
[TBL] [Abstract][Full Text] [Related]
31. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
Gong Q; Zhang P; Wang J; Ma J; An Y; Chen Y; Zhang B; Feng X; Li H; Chen X; Cheng YJ; Gregg EW; Hu Y; Bennett PH; Li G;
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):452-461. PubMed ID: 31036503
[TBL] [Abstract][Full Text] [Related]
32. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
Tuomilehto J; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Louheranta A; Rastas M; Salminen V; Uusitupa M;
N Engl J Med; 2001 May; 344(18):1343-50. PubMed ID: 11333990
[TBL] [Abstract][Full Text] [Related]
33. [Clinical study of the month. Prevention of type 2 diabetes in overweight patients with impaired glucose tolerance: efficiency of lifestyle changes].
Scheen AJ
Rev Med Liege; 2001 Jun; 56(6):463-5. PubMed ID: 11496729
[TBL] [Abstract][Full Text] [Related]
34. Diabetes risk reduction in overweight first degree relatives of type 2 diabetes patients: effects of a low-intensive lifestyle education program (DiAlert) A randomized controlled trial.
Heideman WH; de Wit M; Middelkoop BJ; Nierkens V; Stronks K; Verhoeff AP; Snoek FJ
Patient Educ Couns; 2015 Apr; 98(4):476-83. PubMed ID: 25577471
[TBL] [Abstract][Full Text] [Related]
35. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
Trials; 2015 Nov; 16():496. PubMed ID: 26530718
[TBL] [Abstract][Full Text] [Related]
36. How does lifestyle intervention affect depressive symptoms? Results from the Finnish Diabetes Prevention Study.
Ruusunen A; Voutilainen S; Karhunen L; Lehto SM; Tolmunen T; Keinänen-Kiukaanniemi S; Eriksson J; Tuomilehto J; Uusitupa M; Lindström J
Diabet Med; 2012 Jul; 29(7):e126-32. PubMed ID: 22313027
[TBL] [Abstract][Full Text] [Related]
37. Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.
Davey Smith G; Bracha Y; Svendsen KH; Neaton JD; Haffner SM; Kuller LH;
Ann Intern Med; 2005 Mar; 142(5):313-22. PubMed ID: 15738450
[TBL] [Abstract][Full Text] [Related]
38. Lifestyle interventions for diabetes mellitus type 2 prevention.
Sagarra R; Costa B; Cabré JJ; Solà-Morales O; Barrio F;
Rev Clin Esp (Barc); 2014 Mar; 214(2):59-68. PubMed ID: 24267869
[TBL] [Abstract][Full Text] [Related]
39. Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review.
Norris SL; Zhang X; Avenell A; Gregg E; Bowman B; Schmid CH; Lau J
Am J Prev Med; 2005 Jan; 28(1):126-39. PubMed ID: 15626569
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
